155 related articles for article (PubMed ID: 38152699)
21. Relevance of Assembly-Activating Protein for Adeno-associated Virus Vector Production and Capsid Protein Stability in Mammalian and Insect Cells.
Grosse S; Penaud-Budloo M; Herrmann AK; Börner K; Fakhiri J; Laketa V; Krämer C; Wiedtke E; Gunkel M; Ménard L; Ayuso E; Grimm D
J Virol; 2017 Oct; 91(20):. PubMed ID: 28768875
[TBL] [Abstract][Full Text] [Related]
22. Adeno-associated virus serotypes: vector toolkit for human gene therapy.
Wu Z; Asokan A; Samulski RJ
Mol Ther; 2006 Sep; 14(3):316-27. PubMed ID: 16824801
[TBL] [Abstract][Full Text] [Related]
23. Adeno-associated virus (AAV) capsid engineering in liver-directed gene therapy.
Rodríguez-Márquez E; Meumann N; Büning H
Expert Opin Biol Ther; 2021 Jun; 21(6):749-766. PubMed ID: 33331201
[No Abstract] [Full Text] [Related]
24. Directed evolution of AAV mutants for enhanced gene delivery.
Schaffer DV; Maheshri N
Conf Proc IEEE Eng Med Biol Soc; 2004; 2004():3520-3. PubMed ID: 17271049
[TBL] [Abstract][Full Text] [Related]
25. Structural basis for the neurotropic AAV9 and the engineered AAVPHP.eB recognition with cellular receptors.
Xu G; Zhang R; Li H; Yin K; Ma X; Lou Z
Mol Ther Methods Clin Dev; 2022 Sep; 26():52-60. PubMed ID: 35755945
[TBL] [Abstract][Full Text] [Related]
26. Structural and Biophysical Analysis of Adeno-Associated Virus Serotype 2 Capsid Assembly Variants.
Bennett A; Gargas J; Kansol A; Lewis J; Hsi J; Hull J; Mietzsch M; Tartaglia L; Muzyczka N; Bhattacharya N; Chipman P; Agbandje-McKenna M; McKenna R
J Virol; 2023 Jul; 97(7):e0177222. PubMed ID: 37310260
[TBL] [Abstract][Full Text] [Related]
27. Adeno-associated Virus (AAV) Assembly-Activating Protein Is Not an Essential Requirement for Capsid Assembly of AAV Serotypes 4, 5, and 11.
Earley LF; Powers JM; Adachi K; Baumgart JT; Meyer NL; Xie Q; Chapman MS; Nakai H
J Virol; 2017 Feb; 91(3):. PubMed ID: 27852862
[TBL] [Abstract][Full Text] [Related]
28. Insertional mutagenesis of the adeno-associated virus type 2 (AAV2) capsid gene and generation of AAV2 vectors targeted to alternative cell-surface receptors.
Shi W; Arnold GS; Bartlett JS
Hum Gene Ther; 2001 Sep; 12(14):1697-711. PubMed ID: 11560765
[TBL] [Abstract][Full Text] [Related]
29. The role of the adeno-associated virus capsid in gene transfer.
Van Vliet KM; Blouin V; Brument N; Agbandje-McKenna M; Snyder RO
Methods Mol Biol; 2008; 437():51-91. PubMed ID: 18369962
[TBL] [Abstract][Full Text] [Related]
30. Genetic modification of adeno-associated viral vector type 2 capsid enhances gene transfer efficiency in polarized human airway epithelial cells.
White AF; Mazur M; Sorscher EJ; Zinn KR; Ponnazhagan S
Hum Gene Ther; 2008 Dec; 19(12):1407-14. PubMed ID: 18778196
[TBL] [Abstract][Full Text] [Related]
31. Receptor Switching in Newly Evolved Adeno-associated Viruses.
Havlik LP; Das A; Mietzsch M; Oh DK; Ark J; McKenna R; Agbandje-McKenna M; Asokan A
J Virol; 2021 Sep; 95(19):e0058721. PubMed ID: 34232726
[TBL] [Abstract][Full Text] [Related]
32. Engineered Capsids for Efficient Gene Delivery to the Retina and Cornea.
Frederick A; Sullivan J; Liu L; Adamowicz M; Lukason M; Raymer J; Luo Z; Jin X; Rao KN; O'Riordan C
Hum Gene Ther; 2020 Jul; 31(13-14):756-774. PubMed ID: 32578442
[TBL] [Abstract][Full Text] [Related]
33. Post-translational modifications in capsid proteins of recombinant adeno-associated virus (AAV) 1-rh10 serotypes.
Mary B; Maurya S; Arumugam S; Kumar V; Jayandharan GR
FEBS J; 2019 Dec; 286(24):4964-4981. PubMed ID: 31330090
[TBL] [Abstract][Full Text] [Related]
34. Structural and cellular biology of adeno-associated virus attachment and entry.
Zengel J; Carette JE
Adv Virus Res; 2020; 106():39-84. PubMed ID: 32327148
[TBL] [Abstract][Full Text] [Related]
35. GluA4-Targeted AAV Vectors Deliver Genes Selectively to Interneurons while Relying on the AAV Receptor for Entry.
Hartmann J; Thalheimer FB; Höpfner F; Kerzel T; Khodosevich K; García-González D; Monyer H; Diester I; Büning H; Carette JE; Fries P; Buchholz CJ
Mol Ther Methods Clin Dev; 2019 Sep; 14():252-260. PubMed ID: 31463334
[TBL] [Abstract][Full Text] [Related]
36. Context-Specific Function of the Engineered Peptide Domain of PHP.B.
Martino RA; Fluck EC; Murphy J; Wang Q; Hoff H; Pumroy RA; Lee CY; Sims JJ; Roy S; Moiseenkova-Bell VY; Wilson JM
J Virol; 2021 Sep; 95(20):e0116421. PubMed ID: 34346767
[TBL] [Abstract][Full Text] [Related]
37. Structure of the gene therapy vector, adeno-associated virus with its cell receptor, AAVR.
Meyer NL; Hu G; Davulcu O; Xie Q; Noble AJ; Yoshioka C; Gingerich DS; Trzynka A; David L; Stagg SM; Chapman MS
Elife; 2019 May; 8():. PubMed ID: 31115336
[TBL] [Abstract][Full Text] [Related]
38. AAV vectors engineered to target insulin receptor greatly enhance intramuscular gene delivery.
Jackson CB; Richard AS; Ojha A; Conkright KA; Trimarchi JM; Bailey CC; Alpert MD; Kay MA; Farzan M; Choe H
Mol Ther Methods Clin Dev; 2020 Dec; 19():496-506. PubMed ID: 33313337
[TBL] [Abstract][Full Text] [Related]
39. Mutational analysis of the adeno-associated virus type 2 (AAV2) capsid gene and construction of AAV2 vectors with altered tropism.
Wu P; Xiao W; Conlon T; Hughes J; Agbandje-McKenna M; Ferkol T; Flotte T; Muzyczka N
J Virol; 2000 Sep; 74(18):8635-47. PubMed ID: 10954565
[TBL] [Abstract][Full Text] [Related]
40. Adeno-Associated Virus (AAV) Vectors: Rational Design Strategies for Capsid Engineering.
Lee EJ; Guenther CM; Suh J
Curr Opin Biomed Eng; 2018 Sep; 7():58-63. PubMed ID: 31106283
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
